Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Yom SS, Torres-Saavedra P, Caudell JJ, et al. NRG-HN002: a randomized phase II trial for patients with p16-positive, non-smoking associated, locoregionally advanced oropharyngeal cancer. Intern J Rad Oncol Biol Phys. 2019;105(3):P684-P685.
- Ferris RL, Flamand Y, Weinstein GS, et al. Transoral robotic surgical resection followed by randomization to low- or standard dose IMRT in resectable p16+ locally advanced oropharynx cancer: a trial of the ECOG ACRIN Cancer Research Group (E3311). J Clin Oncol. 2020;38(suppl 15):6500.
- Ferris RL, Flamand Y, Holsinger FC, et al. A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311. Oral Oncol. 2020;110:104797.